By now, most people here in Ohio have heard of the problem with heartburn medications containing rantidine, including Zantac. Testing indicates these medications contain unsafe levels of NDMA, which is a probable human carcinogen. Recently, the Food and Drug Administration ordered the recall of all rantidine products from the market. Now, yet another heartburn medication is being recalled due to the presence of NDMA.
Heartburn medication, Nizatidine, recently recalled
After the rantidine recalls, people began turning to other medications for relief. For instance, Amneal Pharmaceuticals, LLC, recently announced a recall of certain lots of its nizatidine oral solution for the possible presence of unsafe levels of NDMA. This particular medication is prescribed and used for ulcers and the issues associated with gastroesophageal reflux disease.
One of the company’s subsidiaries, Gemini Laboratories, LLC, distributes this particular medication. The customers who received the medication affected by the recall should be quarantined immediately. Consumers are urged to contact their doctors with any complaints while using this product. They may also want to see whether they can obtain a different medication since this may be just the tip of the iceberg when it comes to recalls associated with medications containing nizatidine. After all, the ranitidine recall started out small as well.
Ohio residents may find it more challenging as time goes on to find a medication they can take that will resolve their gastrointestinal issues with heartburn, ulcers and more. So far, only three lots of Nizatidine oral solution are part of the recall, but that could change quickly. Those individuals who suspect taking this medication may have caused them harm may want to gain an understanding of their rights and legal options.
